News on the Division of Blood Diseases and Resources

Dr. Gary Gibbons and Dr. Julie Panepinto
Research Features
The U.S. Food and Drug Administration approved two new gene therapies to treat sickle cell disease — one a gene-editing and the other a gene-addition approach. Nearly 100,000 people in the United States — and millions worldwide — have been diagnosed with this painful, life-threatening genetic blood disease. To help explain the historic importance...
A 3D illustration of a blood clot is shown.
Research Feature
ACTIV-4 research has provided clinicians with guidance for treating and reducing risks for severe COVID outcomes related to inflammation and blood clotting When SARS-CoV-2, the virus that causes COVID-19 , first emerged in late 2019, researchers quickly assembled to understand its effects and figure out how to stop its spread. Soon, late-night...